Today: 28 June 2026
Browse Category

LSE:BEZ 22 January 2026 - 13 June 2026

FTSE 100 Today: Why UK Stocks Are Barely Moving as DCC, Unilever and the BoE Dominate London Trading

FTSE 100 Today: Why UK Stocks Are Barely Moving as DCC, Unilever and the BoE Dominate London Trading

The FTSE 100 rose 0.10% to 10,222.85 in early London trading, recovering after a 1.2% drop on Wednesday. DCC shares fell 5% after rejecting a £4.95 billion takeover bid from KKR and Energy Capital Partners. Unilever began a €1.5 billion share buyback and posted 3.8% underlying sales growth. Investors awaited the Bank of England’s rate decision, with no change expected.
30 April 2026
···········
Beazley Plc Filings Reveal Big Holders as Zurich’s $11 Billion Takeover Gap Holds

Beazley Plc Filings Reveal Big Holders as Zurich’s $11 Billion Takeover Gap Holds

Wellington Management, Vanguard, and Polar Capital disclosed stakes of 6.21%, 5.03%, and 1.33% in Beazley Plc after Zurich Insurance’s £8.1 billion takeover offer. Beazley shares closed Monday at 1,289 pence, 3.4% below Zurich’s 1,335 pence offer. Citadel, D.E. Shaw, and Man Group also reported positions. Zurich expects the deal to close in the second half of 2026, pending approvals.
9 March 2026
··
FTSE 100 today: NatWest buyback lifts UK stocks as Beazley resets Zurich deadline

FTSE 100 today: NatWest buyback lifts UK stocks as Beazley resets Zurich deadline

FTSE 100 rose 0.4% in early trade Monday, led by NatWest after launching a £750 million share buyback. Beazley extended Zurich’s takeover deadline to March 4. Rio Tinto suspended work at its Guinea iron ore project after a fatality. Investors await UK jobs and inflation data this week for signals on Bank of England rate moves.
16 February 2026
·······
Beazley share price sits below Zurich’s £8bn offer — what to watch before London reopens

Beazley share price sits below Zurich’s £8bn offer — what to watch before London reopens

Beazley shares closed flat at 1,236 pence Friday as Zurich faces a Feb. 16 deadline to make a firm takeover offer or withdraw. Zurich and Beazley have agreed in principle on key terms valuing Beazley at up to 1,335 pence per share. Recent filings show Vanguard and FMR LLC among top shareholders. The shares remain below the possible offer price as due diligence continues.
8 February 2026
·
FTSE 100 slips from highs as Bank of England looms; Shell results hit UK shares today

FTSE 100 slips from highs as Bank of England looms; Shell results hit UK shares today

UK stocks slipped Thursday, with the FTSE 100 down 0.2% to 10,382 by 1052 GMT as investors awaited the Bank of England’s rate decision. Shell fell 1.9% after missing profit forecasts but kept its buyback pace. Vodafone dropped 4.7% after launching a €500 million buyback. The STOXX 600 lost 0.5% amid mixed European earnings.
5 February 2026
·······
Beazley share price today: BEZ holds near 1,240p as Zurich bid deadline starts to loom

Beazley share price today: BEZ holds near 1,240p as Zurich bid deadline starts to loom

Beazley shares held steady near 1,240 pence in early London trading Thursday after surging 6.9% on Zurich’s enhanced takeover offer. Zurich and Beazley have agreed in principle on a cash bid of 1,310p plus up to 25p in dividends, with a firm offer deadline set for Feb. 16. The stock remains below the bid price as investors weigh deal risks and await further developments.
5 February 2026
··
FTSE 100 breaks 10,400 as Zurich-Beazley bid and GSK lift UK stocks ahead of BoE

FTSE 100 breaks 10,400 as Zurich-Beazley bid and GSK lift UK stocks ahead of BoE

FTSE 100 rose 1.0% to 10,418.51 by mid-morning Wednesday, with Beazley shares jumping nearly 9% after Zurich raised its takeover bid. GSK gained 2.3% on a positive long-term outlook. AI-linked stocks like RELX and LSEG fell again after recent tech sector jitters. Sterling hit a five-month high against the euro ahead of the Bank of England’s rate decision.
4 February 2026
·····
Zurich’s £8bn Beazley bid jolts FTSE 100 to a fresh record as GSK rallies, AI fears hit data stocks

Zurich’s £8bn Beazley bid jolts FTSE 100 to a fresh record as GSK rallies, AI fears hit data stocks

Zurich Insurance has proposed to buy Beazley for up to 1,335 pence per share, valuing the deal at about £8 billion. Beazley’s board said it would support the offer if Zurich makes a firm bid by Feb. 16. Beazley shares rose 9% on the news. The FTSE 100 hit a new intraday high, with GSK up and Relx and LSEG under pressure from AI concerns.
4 February 2026
·····
Beazley share price steadies, but Zurich bid clock keeps traders on edge heading into Monday

Beazley share price steadies, but Zurich bid clock keeps traders on edge heading into Monday

Beazley shares closed Friday at 1,133 pence, up 0.09%, staying well below Zurich’s 1,280-pence takeover bid. The gap reflects investor uncertainty as Zurich’s £7.67 billion offer remains only a proposal. Barclays and Caxton Associates disclosed new positions, while traders await further takeover filings and Beazley’s results on March 4. Zurich faces a Feb. 16 deadline to formalize or withdraw its bid.
31 January 2026
···
Beazley shares rise again as Zurich bid deadline nears — what to watch when London reopens

Beazley shares rise again as Zurich bid deadline nears — what to watch when London reopens

Beazley shares rose 3.2% to £11.52 on Friday but remain below Zurich’s 1,280p takeover offer, which the board rejected as too low. Zurich faces a Feb. 16 deadline to raise its bid or walk away. Beazley’s board cited a previous 1,315p approach and set March 4 for full-year results. Investors are watching for any revised offer or new bidders.
24 January 2026
···
Beazley share price today: BEZ holds steady as Zurich takeover clock ticks

Beazley share price today: BEZ holds steady as Zurich takeover clock ticks

Beazley shares hovered near 1,117 pence in early London trade Friday, about 13% below Zurich’s 1,280 pence-per-share takeover offer. The UK Takeover Panel set a February 16 deadline for Zurich to declare its intentions. Beazley’s board rejected the offer, calling it too low, after previously turning down a higher bid. Investors are watching for Zurich’s next move and Beazley’s results due March 4.
23 January 2026
·
Beazley Rejects Zurich’s $10bn Takeover Bid as Lloyd’s Plan B Takes Shape

Beazley Rejects Zurich’s $10bn Takeover Bid as Lloyd’s Plan B Takes Shape

Beazley’s board rejected Zurich Insurance’s £8.4 billion all-cash bid at 1,280p per share, calling it a “material undervaluation.” Beazley shares dropped about 3% after the announcement. Zurich faces a UK deadline to confirm or withdraw its offer and is preparing a Lloyd’s syndicate as an alternative entry into the market. Beazley urged shareholders to wait for full-year results due March 4.
22 January 2026
·
1 2

Stock Market Today

  • Goldman Sachs Stock Valuation After 50% Yearly Gain: Overvalued or Time to Pause?
    June 28, 2026, 4:07 AM EDT. Goldman Sachs Group's (GS) stock closed at $1,019.61, down 7% in the last week but up 50.6% over the past year. Despite strong multi-year gains-239.1% over three years-the stock shows a recent pullback. Valuation analysis using an Excess Returns model suggests the stock is about 10.4% overvalued, with an intrinsic value estimate of $923.45 per share versus the current price. The company's Price-to-Earnings (P/E) ratio remains a key metric for assessing investor expectations relative to earnings. This price-behavior mix invites investors to carefully weigh valuation models against robust historical returns and shifting market conditions before considering new positions.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 28.06.2026

28 June 2026
LIVEMarkets rolling coverageStarted: June 28, 2026, 4:00 AM EDTUpdated: June 28, 2026, 4:17 AM EDT Goldman Sachs Stock Valuation After 50% Yearly Gain: Overvalued or Time to Pause? June 28, 2026, 4:07 AM EDT. Goldman Sachs Group’s (GS) stock closed at $1,019.61, down 7% in the last week but up 50.6% over the past year. Despite strong multi-year gains-239.1% over three years-the stock shows a recent pullback. Valuation analysis using an Excess Returns model suggests the stock is about 10.4% overvalued, with an intrinsic value estimate of $923.45 per share versus the current price. The company’s Price-to-Earnings (P/E) ratio remains
Go toTop